Rezultati - Diane Reidy‐Lagunes

Refine Results
  1. 1
    Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned

    Targeted Therapies in Neuroendocrine Tumors (NET): Clinical Trial Challenges and Lessons Learned od James C. Yao, Diane Reidy Lagunes, Matthew H. Kulke

    Izdano 2013
    Polni tekst Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  2. 2
    A Retrospective Review of 126 High-Grade Neuroendocrine Carcinomas of the Colon and Rectum

    A Retrospective Review of 126 High-Grade Neuroendocrine Carcinomas of the Colon and Rectum od James D. Smith, Diane Reidy‐Lagunes, Karyn A. Goodman, Jinru Shia, Garrett M. Nash

    Izdano 2014
    Polni tekst
    Revisão
    Dodaj v priljubljene
    Shranjeno v:
  3. 3
    Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology

    Treatment Response and Outcomes of Grade 3 Pancreatic Neuroendocrine Neoplasms Based on Morphology od Nitya Raj, Emily Valentino, Marinela Capanu, Laura H. Tang, Olca Baştürk, Brian R. Untch, Peter J. Allen, David S. Klimstra, Diane Reidy‐Lagunes

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  4. 4
    A phase 2 study of the insulin‐like growth factor‐1 receptor inhibitor MK‐0646 in patients with metastatic, well‐differentiated neuroendocrine tumors

    A phase 2 study of the insulin‐like growth factor‐1 receptor inhibitor MK‐0646 in patients with metastatic, well‐differentiated neuroendocrine tumors od Diane Reidy‐Lagunes, Efsevia Vakiani, Michal Segal, Ellen Hollywood, Laura H. Tang, David B. Solit, M. Catherine Pietanza, Marinela Capanu, Leonard B. Saltz

    Izdano 2012
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  5. 5
    Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas

    Well-Differentiated Neuroendocrine Tumors with a Morphologically Apparent High-Grade Component: A Pathway Distinct from Poorly Differentiated Neuroendocrine Carcinomas od Laura H. Tang, Brian R. Untch, Diane Reidy‐Lagunes, Eileen M. O’Reilly, Deepti Dhall, Lily Jih, Olca Baştürk, Peter J. Allen, David S. Klimstra

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  6. 6
    Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m<sup>2</sup>/min

    Faster FOLFOX: Oxaliplatin Can Be Safely Infused at a Rate of 1 mg/m<sup>2</sup>/min od Andrea Cercek, Vivian Park, Rona Yaeger, Diane Reidy‐Lagunes, Nancy E. Kemeny, Zsofia K. Stadler, Neil H. Segal, Anna M. Varghese, Leonard B. Saltz

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  7. 7
    Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors

    Biodistribution and radiation dose estimates for 68Ga-DOTA-JR11 in patients with metastatic neuroendocrine tumors od Simone Krebs, Neeta Pandit‐Taskar, Diane Reidy‐Lagunes, Bradley J. Beattie, Serge K. Lyashchenko, Jason S. Lewis, Lisa Bodei, Wolfgang Weber, Joseph A. O’Donoghue

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  8. 8
    Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies

    Response rates of hepatic arterial infusion pump therapy in patients with metastatic colorectal cancer liver metastases refractory to all standard chemotherapies od Andrea Cercek, Taryn Boucher, Jill S. Gluskin, Ariel Aguiló, Joanne F. Chou, Louise C. Connell, Marinela Capanu, Diane Reidy‐Lagunes, Michael I. D’Angelica, Nancy E. Kemeny

    Izdano 2016
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  9. 9
    Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors

    Limited role of Chromogranin A as clinical biomarker for pancreatic neuroendocrine tumors od Alessandra Pulvirenti, Deepthi Rao, Caitlin A. McIntyre, Mithat Gönen, Laura H. Tang, David S. Klimstra, Martin Fleisher, Lakshmi V. Ramanathan, Diane Reidy‐Lagunes, Peter J. Allen

    Izdano 2018
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  10. 10
    False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer

    False-Positive Elevations of Carcinoembryonic Antigen in Patients With a History of Resected Colorectal Cancer od Anya M. Litvak, Andrea Cercek, Neil H. Segal, Diane Reidy‐Lagunes, Zsofia K. Stadler, Rona Yaeger, Nancy E. Kemeny, Martin R. Weiser, Melissa S. Pessin, Leonard B. Saltz

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  11. 11
    Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors

    Multicenter Phase II Trial of Temsirolimus and Bevacizumab in Pancreatic Neuroendocrine Tumors od Timothy J. Hobday, Rui Qin, Diane Reidy‐Lagunes, Malcolm J. Moore, Jonathan Strosberg, Andreas Kaubisch, Manisha H. Shah, Hedy L. Kindler, Heinz‐Josef Lenz, Helen Chen, Charles Erlichman

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  12. 12
    Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer

    Ganetespib, a Novel Hsp90 Inhibitor in Patients With KRAS Mutated and Wild Type, Refractory Metastatic Colorectal Cancer od Andrea Cercek, Jinru Shia, Marc J. Gollub, Joanne F. Chou, Marinela Capanu, Pamela Joan Raasch, Diane Reidy‐Lagunes, David A. Proia, Efsevia Vakiani, David B. Solit, Leonard B. Saltz

    Izdano 2014
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  13. 13
    Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan

    Phase I Trial of Well-Differentiated Neuroendocrine Tumors (NETs) with Radiolabeled Somatostatin Antagonist 177Lu-Satoreotide Tetraxetan od Diane Reidy‐Lagunes, Neeta Pandit‐Taskar, Joseph A. O’Donoghue, Simone Krebs, Kevin D. Staton, Serge K. Lyashchenko, Jason S. Lewis, Nitya Raj, Mithat Gönen, Christian Lohrmann, Lisa Bodei, Wolfgang Weber

    Izdano 2019
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  14. 14
    Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma—A New Look at an Old Drug

    Complete Responses to Mitotane in Metastatic Adrenocortical Carcinoma—A New Look at an Old Drug od Diane Reidy‐Lagunes, Betty Y Lung, Brian R. Untch, Nitya Raj, Anastasia E. Hrabovsky, Ciara M. Kelly, Scott R. Gerst, Seth S. Katz, Lewis J. Kampel, Joanne F. Chou, Anu Gopalan, Leonard B. Saltz

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  15. 15
    Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies

    Biodistribution and Dosimetry of <sup>18</sup>F-Meta-Fluorobenzylguanidine: A First-in-Human PET/CT Imaging Study of Patients with Neuroendocrine Malignancies od Neeta Pandit‐Taskar, Pat Zanzonico, Kevin D. Staton, Jorge A. Carrasquillo, Diane Reidy‐Lagunes, Serge K. Lyashchenko, Eva Burnazi, Hanwen Zhang, Jason S. Lewis, Ronald G. Blasberg, Steven M. Larson, Wolfgang Weber, Shakeel Modak

    Izdano 2017
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  16. 16
    Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastatic Colorectal Cancer

    Randomized, Phase II Study of the Insulin-Like Growth Factor-1 Receptor Inhibitor IMC-A12, With or Without Cetuximab, in Patients With Cetuximab- or Panitumumab-Refractory Metastat... od Diane Reidy‐Lagunes, Efsevia Vakiani, Marwan Fakih, Muhammad Wasif Saif, J. Randolph Hecht, Noah Goodman-Davis, Ellen Hollywood, Jinru Shia, Jonathan Schwartz, Kumari Chandrawansa, Aruna Dontabhaktuni, Hagop Youssoufian, David B. Solit, Leonard B. Saltz

    Izdano 2010
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  17. 17
    Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial

    Neoadjuvant Chemotherapy Without Routine Use of Radiation Therapy for Patients With Locally Advanced Rectal Cancer: A Pilot Trial od Deborah Schrag, Martin R. Weiser, Karyn A. Goodman, Mithat Gönen, Ellen Hollywood, Andrea Cercek, Diane Reidy‐Lagunes, Marc J. Gollub, Jinru Shia, José G. Guillem, Larissa K. Temple, Philip B. Paty, Leonard B. Saltz

    Izdano 2014
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  18. 18
    Pilot Trial of Combined BRAF and EGFR Inhibition in <i>BRAF</i>-Mutant Metastatic Colorectal Cancer Patients

    Pilot Trial of Combined BRAF and EGFR Inhibition in <i>BRAF</i>-Mutant Metastatic Colorectal Cancer Patients od Rona Yaeger, Andrea Cercek, Eileen M. O’Reilly, Diane Reidy‐Lagunes, Nancy E. Kemeny, Tamar Wolinsky, Marinela Capanu, Marc J. Gollub, Neal Rosen, Michael F. Berger, Mario E. Lacouture, Efsevia Vakiani, Leonard B. Saltz

    Izdano 2015
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  19. 19
    NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy

    NANETS/SNMMI Consensus Statement on Patient Selection and Appropriate Use of <sup>177</sup>Lu-DOTATATE Peptide Receptor Radionuclide Therapy od Thomas A. Hope, Lisa Bodei, Jennifer A. Chan, Ghassan El‐Haddad, Nicholas Fidelman, Pamela L. Kunz, Josh Mailman, Yusuf Menda, David C. Metz, Erik Mittra, Daniel A. Pryma, Diane Reidy‐Lagunes, Simron Singh, Jonathan Strosberg

    Izdano 2020
    Polni tekst Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:
  20. 20
    Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability

    Real-Time Genomic Characterization of Metastatic Pancreatic Neuroendocrine Tumors Has Prognostic Implications and Identifies Potential Germline Actionability od Nitya Raj, Ronak Shah, Zsofia K. Stadler, Semanti Mukherjee, Joanne F. Chou, Brian R. Untch, Janet Li, Virginia Kelly, Muyinat Osoba, Leonard B. Saltz, Diana Mandelker, Marc Ladanyi, Michael F. Berger, David S. Klimstra, Diane Reidy‐Lagunes

    Izdano 2018
    Polni tekst
    Artigo
    Dodaj v priljubljene
    Shranjeno v:

Iskalna orodja: